(2024) 30:S3954
Webinar Replay: GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels
GLP-1 receptor agonists should be considered when patients experience significant weight regain with BMI 27 kg/m with obesity-related comorbidities or BMI 30 kg/m, lifestyle modifications have been insufficient, no anatomical complications require surgical revision, and patients are willing to engage in long-term pharmacotherapy
The GI side effects, nausea, disrupted digestion, variable appetite, make the final prep phase significantly harder to manage with semaglutide active in your system
Individual variation in gut microbiome composition, diet, and metabolic response to the medication all play a role
Myth: If you have great oral hygiene, you have nothing to worry about